SUTRO BIOPHARMA, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $470.7M
Liabilities Breakdown FY2023
Total Liabilities: $321.1M
Asset Breakdown
Total Assets: $470.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $69.3M | 14.7% |
| Accounts Receivable | $36.1M | 7.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $21.9M | 4.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $343.5M | 73.0% |
Liabilities Breakdown
Total Liabilities: $321.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.4M | 2.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $311.6M | 97.1% |